Literature DB >> 15100994

Drug resistance in Chromobacterium violaceum.

Fabiana Fantinatti-Garboggini1, Rosana de Almeida, Vinícius do Amaral Portillo, Tércio A P Barbosa, Peterson Beltramini Trevilato, Cícero Eduardo Ramalho Neto, Rosângela Duarte Coêlho, Denise Wanderlei Silva, Luciana Aparecida Bartoleti, Ebert Seixas Hanna, Marcelo Brocchi, Gilson P Manfio.   

Abstract

Chromobacterium violaceum is a free-living bacterium commonly found in aquatic habitats of tropical and subtropical regions of the world. This bacterium is able to produce a large variety of products of biotechnological and pharmacological use. Although C. violaceum is considered to be non-pathogenic, some cases of severe infections in humans and other animals have been reported. Genomic data on the type strain ATCC 12472(T) has provided a comprehensive basis for detailed studies of pathogenicity, virulence and drug resistance genes. A large number of open reading frames associated with various mechanisms of drug resistance were found, comprising a remarkable feature of this organism. Amongst these, beta-lactam (penicillin and cephalosporin) and multidrug resistance genes (drug efflux pumps) were the most numerous. In addition, genes associated with bacitracin, bicyclomycin, chloramphenicol, kasugamycin, and methylenomycin were also found. It is postulated that these genes contribute to the ability of C. violaceum to compete with other bacteria in the environment, and also may help to explain the common drug resistance phenotypes observed in infections caused by this bacterium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100994

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  16 in total

1.  Fatal wound infection caused by Chromobacterium violaceum in Ho Chi Minh City, Vietnam.

Authors:  Stephen Baker; James I Campbell; Richard Stabler; Hoang V M Nguyen; Diep S To; Dung V Nguyen; Jeremy Farrar
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

3.  Chromobacterium violaceum infections in 13 non-human primates.

Authors:  David X Liu; Peter J Didier; Gail B Plauche
Journal:  J Med Primatol       Date:  2011-12-29       Impact factor: 0.667

4.  The Brief Case: Recurrent Chromobacterium violaceum Bloodstream Infection in a Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patient with a Severe Neutrophil Defect.

Authors:  Phyu M Thwe; Daniel A Ortiz; Alyssa L Wankewicz; J Patrik Hornak; Natalie Williams-Bouyer; Ping Ren
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

5.  Efflux Pumps in Chromobacterium Species Increase Antibiotic Resistance and Promote Survival in a Coculture Competition Model.

Authors:  Saida Benomar; Kara C Evans; Robert L Unckless; Josephine R Chandler
Journal:  Appl Environ Microbiol       Date:  2019-09-17       Impact factor: 4.792

6.  The extracellular proteome of Rhizobium etli CE3 in exponential and stationary growth phase.

Authors:  Niurka Meneses; Guillermo Mendoza-Hernández; Sergio Encarnación
Journal:  Proteome Sci       Date:  2010-10-14       Impact factor: 2.480

7.  Violacein-producing Collimonas sp. from the sea surface microlayer of costal waters in Trøndelag, Norway.

Authors:  Sigrid Hakvåg; Espen Fjaervik; Geir Klinkenberg; Sven Even F Borgos; Kjell D Josefsen; Trond E Ellingsen; Sergey B Zotchev
Journal:  Mar Drugs       Date:  2009-11-12       Impact factor: 5.118

Review 8.  Chromobacterium violaceum: A Review of an Unexpected Scourge.

Authors:  Bachti Alisjahbana; Josephine Debora; Evan Susandi; Guntur Darmawan
Journal:  Int J Gen Med       Date:  2021-07-09

9.  A successful antimicrobial regime for Chromobacterium violaceum induced bacteremia.

Authors:  James I Campbell; Nguyen Phu Huong Lan; Phan Tu Qui; Le Thi Dung; Jeremy J Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2013-01-04       Impact factor: 3.090

10.  Analysis of Chromobacterium sp. natural isolates from different Brazilian ecosystems.

Authors:  Cláudia I Lima-Bittencourt; Spartaco Astolfi-Filho; Edmar Chartone-Souza; Fabrício R Santos; Andréa M A Nascimento
Journal:  BMC Microbiol       Date:  2007-06-21       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.